• Preventing Quantum Cyberattacks

    From defense and health information to social networking and banking transactions, communications increasingly rely on cryptographic security amid growing fears of cyberattacks. However, can such sensitive data be unhackable?

  • Online Economic Decision Tool to Help Communities Plan for Disaster

    Preparing a community’s buildings and infrastructure for a hurricane or earthquake can be an incredibly complicated and costly endeavor. A new online tool from NIST could streamline this process and help decision makers invest in cost-effective measures to improve their community’s ability to mitigate, adapt to and recover from hazardous events.

  • COVID-19 Preventative Vaccine Trial for Healthcare Workers

    Professor Kathryn North AC, Director of the Murdoch Children’s Research Institute in Melbourne, Australia, has announced its infectious disease researchers are preparing to roll-out a multi-center randomised controlled clinical trial of the BCG vaccine against COVID-19. 
    The trial has been endorsed by the Director-General of the WHO, Tedros Adhanom, who has called for global support and assistance in the fight against COVID-19.  

  • Initial Results of a New Symptom Tracking App: About 10% of Britons Are Infected

    The first app monitoring symptoms of people in Britain with suspected coronavirus shows that, at present, one in 10 users have a mild form of the virus at present. The app, developed by researchers in King’s College London, was made available to the public on Wednesday. Within the first 24 hours of the app being made available, some 650,000 people had signed up – and an initial analysis revealed that 10 percent of people were showing mild symptoms of the virus.

  • App Helps Doctors Find the Right Dose of Corona Medication

    Researchers have developed an app that doctors can use to more easily determine the right dosage of medication for corona patients. At the moment, doctors are prescribing many existing kinds of medication to patients. Using the app, they can determine a safe and effective dosage.

  • Body Armor for Women in Law Enforcement

    Law enforcement in the United States remains a male-dominated profession. According to recent reports, less than 13 percent of full-time officers are female. So, it stands to reason that the ballistic-resistant body armor worn by law enforcement officers in the field has traditionally been designed for the male build. As the number of women entering the field continues to rise, so too has the demand for personal protective equipment (PPE) that is designed for the female physique.

  • Protecting U.S. Energy Grid and Nuclear Weapons Systems

    To deter attempts to disable U.S. electrical utilities and to defend U.S. nuclear weapon systems from evolving technological threats, Sandia researchers have begun two multiyear initiatives to strengthen U.S. responses.

  • Bolstering Realistic Radiation Training

    The Radiation Field Training Simulator (RaFTS) technology provides a first responder training solution that can be used to protect against acts of radiological or nuclear terrorism and to deal with their subsequent aftermath.

  • Fusion Researchers Endorse Push for Pilot Power Plant in U.S.

    The growing sense of urgency around development of fusion technology for energy production in the United States got another boost this week with the release of a community consensus report by a diverse group of researchers from academia, government labs, and industry. High among its recommendations is development of a pilot fusion power plant, an ambitious goal that would be an important step toward an American fusion energy industry.

  • COVID-19 Treatment Might Already Exist in Old Drugs – We’re Using Pieces of the Coronavirus Itself to Find Them

    As a systems biologist who studies how cells are affected by viruses during infections, I’m interested in the question how long will it take to develop drugs to treat COVID-19. Finding points of vulnerability and developing a drug to treat a disease typically takes years. But the new coronavirus isn’t giving the world that kind of time. With most of the world on lockdown and the looming threat of millions of deaths, researchers need to find an effective drug much faster.

  • Making Bioweapons Obsolete

    As the threats posed by bioterrorism and naturally occurring infectious disease grow and evolve in the modern era, there is a rising potential for broad negative impacts on human health, economic stability and global security. To protect the United States from these dangers, researchers are taking on the ambitious goal of making bioweapons obsolete.

  • Safe, Fast Radionuclide Detection

    In the event of a radiological release, such as from an improvised nuclear device, immediately assessing the threat to public safety would be critical. Rapid detection of radioactive materials can save lives, reduce the environmental impact of such an event and save taxpayer dollars. Current hand-held detection methods, however, are unreliable at detecting very low levels of alpha radiation from actinides, such as uranium, due to environmental influences.

  • COVID-19 Diagnostic Based on MIT Technology Might Be Tested on Patient Samples Soon

    As more COVID-19 cases appear in the United States and around the world, the need for fast, easy-to-use diagnostic tests is becoming ever more pressing. A startup company spun out from MIT is now working on a paper-based test that can deliver results in under half an hour, based on technology developed at MIT’s Institute for Medical Engineering and Science (IMES). A variety of MIT research projects could aid efforts to detect and prevent the spread of coronavirus.

  • Oxford Scientists Develop Rapid Testing Technology for COVID-19

    Oxford University scientists have developed a rapid testing technology for the novel corona virus SARS-CoV-2 (COVID-19). The new test is much faster and does not need a complicated instrument. Previous viral RNA tests took 1.5 to 2 hours to give a result. The research team has developed a new test, based on a technique which is capable of giving results in just half an hour – over three times faster than the current method.

  • COVID-19 Virus Isolated: Better Testing, Treatments, Vaccines Near

    Canadian researchers have isolated SARS-CoV-2 (coronavirus 2), the agent responsible for the ongoing outbreak of COVID-19, bringing the world closer to developing better diagnostic testing, treatments, and vaccines, and gaining a better understanding of SARS-CoV-2 biology, evolution, and clinical shedding. Researchers in North Carolina said Thursday that they produced a Virus-Like Particle (VLP) of the novel coronavirus, marking the first step in Covid-19 vaccine development.